May 25th, 2003 - 02:00 GMT Teva Pharmaceutical Industries reports 39 percent net sales increase Israel’s Teva Pharmaceutical Industries recorded a net income of $138 million for the first quarter of 2003 and fully diluted EPS of $0.50, an increase over the first quarter of 2002 of 61 percent and Read more
